Market Research Logo

Infectious Disease Drugs: The Chinese Market

Infectious Disease Drugs: The Chinese Market

The Chinese infectious disease drugs market reached $32.2 billion in 2016. The market should reach $61.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 13.9% from 2016 to 2021.

Report Includes
An overview of the Chinese market for infectious disease drugs.
Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
Discussion of the increasing concern regarding antibiotic-resistant organisms and their sometimes-fatal effects on humans.
Examination of technological developments, future trends, and emerging opportunities.
Assessments of the current state of infectious diseases on a global basis, broken down by type of disease (i.e., bacterial, viral, parasitic, and fungal) and appropriate treatments, both current and anticipated, and by geographic region.
Profiles of major players in the field of infectious disease treatments.


Report Scope
The scope of the report includes infectious disease drugs applications, industries, markets and companies in China. The markets for infectious disease drugs are given for the years 2015, 2016 and 2021.

The report covers the Chinese market for both communicable and noncommunicable infectious disease drugs. In this report, communicable infectious diseases only refer to the 39 statutory communicable diseases stated by the National Health and Family Planning Commission of the People's Republic of China (NHFPC). They include viral hepatitis, pulmonary tuberculosis, syphilis, bacillary/amebic dysentery, gonorrhea, scarlet fever, brucellosis, acquired immunodeficiency syndrome (AIDS), hand-foot-and-mouth disease, infectious diarrhea, influenza, and epidemic parotitis.

In this report, China is referred to as Mainland China. It does not include Hong Kong, Macao and Taiwan. Mainland China has a total of 31 province-level regions, including 22 provinces, four province-level municipalities (cities) and five province-level autonomous regions. Important geographic markets will be discussed, including Beijing, Shanghai, Guangdong and others.

More than 100 Chinese companies in the infectious disease drug industry are profiled in this report.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
METHODOLOGY
INFORMATION SOURCES
ANALYSTS' CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
SUMMARY TABLE VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET, BY DISEASE TYPE, 2015-2021 ($ MILLIONS)
LARGEST AND FASTEST-GROWING MARKETS
LARGEST INFECTIOUS DISEASE DRUG MARKETS
FAST-GROWING INFECTIOUS DISEASE DRUG MARKETS
LAWS, REGULATIONS AND TARGETS
PHARMACEUTICAL ADMINISTRATION LAW OF THE PEOPLE'S REPUBLIC OF CHINA
PROCUREMENT AND BIDDING MANAGEMENT OF THE CHINA FOOD AND DRUG
ADMINITRATION
ADMINISTRATIVE MEASURES FOR THE CLINICAL USE OF ANTIBACTERIAL
DRUGS
LIMITATION OF ANTIBACTERIAL DRUGS
CHAPTER 3 THE CHINESE DRUG MARKET
CHINESE DRUG MARKET BY SALES CHANNELS
TABLE 1 VALUE OF CHINESE DRUG END-CONSUMER MARKET, BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)
FIGURE 1 VALUE OF CHINESE DRUG END-CONSUMER MARKET, BY SALES CHANNELS, 2015-2021 ($ MILLIONS)
SUPPLY CHAIN AND PRICING STRUCTURE
FIGURE 2 DRUG SUPPLY CHAIN IN CHINA
Hospitals
Retailers
RETAIL MARKET
Chinese Drug Retail Market by Drug Type
TABLE 2 VALUE OF THE CHINESE DRUG MARKET BY RETAIL CHANNEL BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
Chinese Traditional Drugs in the Retail Market
TABLE 3 CHINESE RETAIL TRADITIONAL DRUGS SALES BY MAJOR DRUG TYPE, 2015 ($ MILLIONS/%)
TABLE 4 CHINESE RETAIL TRADITIONAL PATENT DRUG SALES BY DRUG TYPE, 2015 ($ MILLIONS/%)
Chemical and Biological Drugs in the Chinese Retail Market
TABLE 5 CHINESE RETAIL CHEMICAL AND BIOLOGICAL DRUG SALES BY DRUG TYPE, 2015 ($ MILLIONS/%)
Chinese Retail Market by Drug Stores
TABLE 6 CHINESE DRUG RETAIL SALES BY RETAIL COMPANY, 2015 ($ MILLIONS/%)
Chinese Hospital Drug Market
TABLE 7 VALUE OF THE CHINESE DRUG MARKET IN HOSPITALS, BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
Chinese Traditional Drugs Sold in Hospitals
TABLE 8 MARKET SHARES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE AND DRUG TYPE, 2015 (%)
TABLE 9 MARKET VALUES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE AND DRUG TYPE, 2015 ($ MILLIONS)
TABLE 10 MARKET VALUES OF CHINESE TRADITIONAL DRUGS SOLD IN HOSPITALS, BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
Chemical and Biological Drugs Sold in Hospitals
TABLE 11 MARKET SHARES OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE AND DRUG TYPE, 2015 (%)
TABLE 12 MARKET VALUE OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS IN 2015 BY HOSPITAL TYPE AND DRUG TYPE ($MILLIONS)
TABLE 13 MARKET VALUES OF CHEMICAL AND BIOLOGICAL DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
CHINESE DRUG MARKET BY DRUG TYPE
TABLE 14 VALUE OF THE CHINESE DRUG MARKET BY DRUG TYPE, THROUGH 2021 ($ MILLIONS)
THE CHINESE TRADITIONAL DRUG MARKET BY MAJOR SALES CHANNELS
TABLE 15 VALUE OF CHINESE TRADITIONAL DRUGS BY SALES CHANNELS
THROUGH 2021 ($ MILLIONS)
THE CHINESE CHEMICAL AND BIOLOGICAL DRUG MARKET BY MAJOR SALES CHANNELS
TABLE 16 VALUE OF CHINESE CHEMICAL AND BIOLOGICAL DRUGS BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)
CHAPTER 4 CHINESE INFECTIOUS DISEASE DRUG MARKET BY DISEASE
TABLE 17 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 3 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
MOST COMMON 39 COMMUNICABLE DISEASES
TABLE 18 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 4 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
COMMUNICABLE DISEASES IN CHINA
TABLE 19 NUMBER OF COMMUNICABLE DISEASES BY MAJOR TYPE IN CHINA, 2015
Category A Communicable Diseases
TABLE 20 NUMBER OF CHINESE CATEGORY-A COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
Category B Communicable Diseases
TABLE 21 NUMBER OF CHINESE CATEGORY B COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
Category C Communicable Diseases
TABLE 22 NUMBER OF CHINESE CATEGORY C COMMUNICABLE DISEASES BY MAJOR DISEASE, 2015
History
THE CHINESE COMMUNICABLE DISEASE DRUG MARKET BY DISEASE TYPE
Viral Hepatitis
TABLE 23 VALUE OF CHINESE VIRAL HEPATITIS DRUG MARKET BY MAJOR TYPE, 2015 ($ MILLIONS/%)
Pulmonary Tuberculosis
TABLE 24 VALUE OF CHINESE PULMONARY TUBERCULOSIS DRUG MARKET BY MAJOR TYPE, 2015 ($ MILLIONS/%)
AIDS
Infective Keratitis and Conjunctivitis
TABLE 25 VALUE OF CHINESE INFECTIVE KERATITIS/CONJUNCTIVITIS DRUG MARKET BY MAJOR DRUG TYPE, 2015 ($ MILLIONS/%)
OTHER INFECTIOUS DISEASES
ACINETOBACTER INFECTIONS
ACTINOMYCOSIS
AMOEBIASIS
ANTHRAX
ASPERGILLOSIS
BACTERIAL PNEUMONIA
VIRAL PNEUMONIA
CHAPTER 5 CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCTS TOP 30 AND TOP 100 INFECTIOUS DISEASE DRUGS IN CHINA
TABLE 26 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)
FIGURE 5 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR DISEASE TYPE, 2015-2021 ($ MILLIONS)
TABLE 27 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)
ENTECAVIR
Chinese Entecavir Market by Sales Channels
TABLE 28 VALUE OF CHINESE ENTECAVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 6 VALUE OF CHINESE ENTECAVIR MARKET BY SALES CHANNEL, 2015 (%)
Chinese Entecavir Market by Manufacturers
TABLE 29 CHINESE ENTECAVIR MARKET BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
TABLE 30 VALUE OF CHINESE ENTECAVIR MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
PIPERACILLIN-TAZOBACTAM (INJECTION)
TABLE 31 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 7 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 (%)
MEROPENEM (INJECTION)
Chinese Meropenem Market by Sales Channels
TABLE 32 VALUE OF CHINESE INJECTIVE MEROPENEM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 8 VALUE OF CHINESE INJECTIVE MEROPENEM MARKET BY SALES CHANNEL, 2015 (%)
Chinese Meropenem Market by Drugmakers
TABLE 33 VALUE OF CHINESE MEROPENEM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
CEFPERAZONE-SULBACTAM (INJECTION)
Chinese Cefperazone-Sulbactam Market by Sales Channels
TABLE 34 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 9 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY SALES CHANNEL, 2015 (%)
Chinese Cefperazone-Sulbactam Market by Drugmakers
TABLE 35 VALUE OF CHINESE INJECTIVE CEFPERAZONE-SULBACTAM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
LEVOFLOXACIN (INJECTION)
TABLE 36 VALUE OF CHINESE LEVOFLOXACIN MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
Chinese Levofloxacin Market by Sales Channels
Injective Levofloxacin
TABLE 37 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 10 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Oral Levofloxacin
TABLE 38 VALUE OF CHINESE ORAL LEVOFLOXACIN TABLET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
Chinese Injective Levofloxacin Market by Drugmakers
TABLE 39 VALUE OF CHINESE INJECTIVE LEVOFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
CEFOPERAZONE-TAZOBACTAM (INJECTION)
TABLE 40 VALUE OF CHINESE INJECTIVE CEFOPERAZONE-TAZOBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 11 VALUE OF CHINESE INJECTIVE CEFOPERAZONE-TAZOBACTAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
CEFUROXIMEE (INJECTION)
TABLE 41 VALUE OF CHINESE CEFUROXIMEE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
TABLE 42 VALUE OF CHINESE INJECTIVE CEFUROXIMEE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 12 VALUE OF CHINESE INJECTIVE CEFUROXIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
CEFOTIAM (INJECTION)
Chinese Cefotiam Market by Sales Channels
TABLE 43 VALUE OF CHINESE INJECTIVE CEFOTIAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 13 VALUE OF CHINESE INJECTIVE CEFOTIAM MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Cefotiam Market by Drugmakers
TABLE 44 VALUE OF CHINESE CEFOTIAM MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
CEFATHIAMIDINE (INJECTION)
Chinese Cefathiamidine Market by Sales Channels
TABLE 45 VALUE OF CHINESE INJECTIVE CEFATHIAMIDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 14 VALUE OF CHINESE INJECTIVE CEFATHIAMIDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Cefathiamidine Market by Drugmakers
TABLE 46 VALUE OF CHINESE CEFATHIAMIDINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
IMIPENEM-CILASTATIN (INJECTION)
Chinese Imipenem/Cilastatin Market by Sales Channels
TABLE 47 VALUE OF CHINESE INJECTIVE IMIPENEM/CILASTATIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 15 VALUE OF CHINESE INJECTIVE IMIPENEM/CILASTATIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Imipenem/Cilastatin Market by Drugmakers
TABLE 48 VALUE OF CHINESE IMIPENEM/CILASTATIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
VORICONAZOLE (INJECTION)
TABLE 49 VALUE OF CHINESE VORICONAZOLE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
Chinese Injective Voriconazole Market by Sales Channels
TABLE 50 VALUE OF CHINESE INJECTIVE VORICONAZOLE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 16 VALUE OF CHINESE INJECTIVE VORICONAZOLE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Voriconazole Market by Drugmakers
TABLE 51 VALUE OF CHINESE VORICONAZOLE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
MOXIFLOXACIN (INJECTION AND TABLETS)
TABLE 52 VALUE OF CHINESE MOXIFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
Chinese Moxifloxacin Market by Sales Channels
TABLE 53 VALUE OF CHINESE MOXIFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 17 VALUE OF CHINESE MOXIFLOXACIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Moxifloxacin Market by Drugmakers
TABLE 54 VALUE OF CHINESE MOXIFLOXACIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
CEFOXITIN (INJECTION)
Chinese Injective Cefoxitin Market by Sales Channels
TABLE 55 VALUE OF CHINESE INJECTIVE CEFOXITIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 18 VALUE OF CHINESE INJECTIVE CEFOXITIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Cefoxitin Market by Drugmakers
TABLE 56 VALUE OF CHINESE CEFOXITIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
LATAMOXEF (INJECTION)
Chinese Injective Latamoxef Market by Sales Channels
TABLE 57 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 19 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Latamoxef Market by Drugmakers
TABLE 58 VALUE OF CHINESE INJECTIVE LATAMOXEF MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
CEFTRIAXONE (INJECTION)
Chinese Injective Ceftriaxone Market by Sales Channels
TABLE 59 VALUE OF CHINESE INJECTIVE CEFTRIAXONE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 20 VALUE OF CHINESE INJECTIVE CEFTRIAXONE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Ceftriaxone Market by Drugmakers
TABLE 60 VALUE OF CHINESE CEFTRIAXONE MARKET BY PRODUCER, 2015 ($ MILLIONS/%)
ADEFOVIR
Chinese Adefovir Market by Sales Channels
TABLE 61 VALUE OF CHINESE ADEFOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 21 VALUE OF CHINESE ADEFOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Adefovir Market by Manufacturers
TABLE 62 CHINESE ADEFOVIR MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
TABLE 63 VALUE OF CHINESE ADEFOVIR MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
LAMIVUDINE
Chinese Lamivudine Market by Sales Channels
TABLE 64 VALUE OF CHINESE LAMIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 22 VALUE OF CHINESE LAMIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Lamivudine Market by Manufacturers
TABLE 65 CHINESE LAMIVUDINE MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
TABLE 66 VALUE OF CHINESE LAMIVUDINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
CEFAZOLIN (INJECTION)
Chinese Injective Cefazolin Market by Sales Channels
TABLE 67 VALUE OF CHINESE INJECTIVE CEFAZOLIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 23 VALUE OF CHINESE INJECTIVE CEFAZOLIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Cefazolin Market by Drugmakers
TABLE 68 VALUE OF CHINESE CEFAZOLIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
CEFTAZIDIME (INJECTION)
TABLE 69 VALUE OF CHINESE CEFAZOLIN MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
Chinese Injective Ceftazidime Market by Sales Channels
TABLE 70 VALUE OF CHINESE INJECTIVE CEFTAZIDIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 24 VALUE OF CHINESE INJECTIVE CEFTAZIDIME MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Injective Ceftazidime Market by Drugmakers
TABLE 71 VALUE OF CHINESE CEFTAZIDIME MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
TELBIVUDINE
TABLE 72 VALUE OF CHINESE TELBIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 25 VALUE OF CHINESE TELBIVUDINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
OTHER DRUGS
Cefixime
TABLE 73 VALUE OF CHINESE CEFIXIME MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
TABLE 74 VALUE OF CHINESE CEFIXIME MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
Amoxicillin-Clavulanate
TABLE 75 VALUE OF CHINESE AMOXICILLIN-CLAVULANATE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
Itraconazole
TABLE 76 VALUE OF CHINESE ITRACONAZOLE MARKET BY DRUG FORMS, 2015 ($ MILLIONS/%)
TABLE 77 VALUE OF CHINESE ITRACONAZOLE MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
Cefaclor
TABLE 78 VALUE OF CHINESE CEFACLOR MARKET BY DRUG FORMS, 2015 ($ MILLIONS/%)
TABLE 79 VALUE OF CHINESE CEFACLOR MARKET BY SALES CHANNELS, 2015 ($ MILLIONS/%)
Vidarabine (Injection)
Chinese Vidarabine Market by Sales Channels
TABLE 80 VALUE OF CHINESE VIDARABINE INJECTION MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 26 VALUE OF CHINESE VIDARABINE MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Chinese Vidarabine Market by Manufacturers
TABLE 81 CHINESE VIDARABINE MARKET SHARE BY SALES CHANNEL AND LEADING SUPPLIER, 2015 (%)
TABLE 82 VALUE OF CHINESE VIDARABINE MARKET BY PRODUCERS, 2015 ($ MILLIONS/%)
Valacyclovir Tablets
TABLE 83 VALUE OF CHINESE VALACYCLOVIR TABLET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 27 VALUE OF CHINESE VALACYCLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Ganciclovir (Injection)
TABLE 84 VALUE OF CHINESE INJECTIVE GANCICLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 28 VALUE OF CHINESE GANCICLOVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Foscarnet for Injection
TABLE 85 VALUE OF CHINESE INJECTIVE FOSCARNET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 29 VALUE OF CHINESE FOSCARNET MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Oseltamivir Tablets
TABLE 86 VALUE OF CHINESE OSELTAMIVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
FIGURE 30 VALUE OF CHINESE OSELTAMIVIR MARKET BY SALES CHANNEL, 2015 ($ MILLIONS)
Ribavirin
TABLE 87 VALUE OF CHINESE RIBAVIRIN MARKET BY SALES CHANNEL, 2015 ($ MILLIONS/%)
TABLE 31 VALUE OF CHINESE INJECTIVE PIPERACILLIN-TAZOBACTAM MARKET, BY SALES CHANNEL, 2015 ($ MILLIONS/%)
CHAPTER 6 CHINESE INFECTIOUS DISEASE DRUGS BY PRODUCERS
TABLE 88 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 32 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY PRODUCER TYPE, 2015-2021 ($ MILLIONS)
TABLE 89 CHINESE INFECTIOUS DISEASE DRUG MARKETBY PRODUCER GROUP, 2015 ($ MILLIONS/%)
CHINESE HOMEGROWN DRUGMAKERS
TABLE 90 CHINESE HOMEGROWN DRUGMAKERS AND THEIR SALES IN CHINA, 2015 ($ MILLIONS/%)
GUANGZHOU PHARMACEUTICAL
TABLE 91 GUANGZHOU PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
HARBIN PHARMACEUTICAL
TABLE 92 HARBIN PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
NORTH CHINA PHARMACEUTICAL
TABLE 93 NORTH CHINA PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
YANGTZE RIVER PHARMACEUTICAL
TABLE 94 YANGTZE RIVER PHARMACEUTICAL'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
REYOUNG PHARMACEUTICAL
CHIATAI TIANQING
TABLE 95 CHIATAI TIANQING'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
HAILINGPHARM
TABLE 96 HAILINGPHARM’S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
FOREIGN DRUG MARKETS IN THE CHINESE MARKET
TABLE 97 CHINESE HOMEGROWN DRUGMAKERS AND THEIR SALES IN CHINA, 2015 ($ MILLIONS/%)
PFIZER
TABLE 98 PFIZER'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
GSK
TABLE 99 GSK'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
MSD
TABLE 100 MSD'S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
BAYER HEALTHCARE
TABLE 101 BAYER HEALTHCARE’S SALES OF INFECTIOUS DISEASE DRUGS BY DRUG, 2015 ($ MILLIONS/%)
CHAPTER 7 THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS
TABLE 102 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, THROUGH 2021 ($ MILLIONS)
FIGURE 33 VALUE OF CHINESE INFECTIOUS DISEASE DRUG MARKET BY SALES CHANNELS, 2015-2021 ($ MILLIONS)
CHINESE INFECTIOUS DISEASE DRUGS RETAIL MARKET
CHINESE INFECTIOUS DISEASE DRUGS RETAIL MARKET BY RETAILERS
TABLE 103 CHINESE RETAIL DRUG MARKET, BY RETAILERS, 2015 ($ MILLIONS/%)
CHINESE INFECTIOUS DISEASE DRUGS RETAIL MARKET BY DRUGS
TABLE 104 CHINESE RETAIL DRUG MARKET BY DRUG PRODUCT, 2015 ($ MILLIONS/%)
Cefixime
TABLE 105 CHINESE RETAIL CEFIXIME MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
Entecavir
TABLE 106 CHINESE RETAIL ENTERCAVIR MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
Adefovir
TABLE 107 CHINESE RETAIL ADEFORVIR MARKET BY DRUG FORM, 2015 ($ MILLIONS/%)
CHINESE HOSPITAL MARKET FOR INFECTIOUS DISEASE DRUGS
TABLE 108 CHINESE MARKET VALUES OF INFECTIOUS DISEASE DRUGS SOLD IN HOSPITALS BY HOSPITAL TYPE, THROUGH 2021 ($ MILLIONS)
TABLE 109 NUMBER OF HOSPITALS IN CHINA BY TYPE, 2015
CITY AND COUNTY HOSPITALS
TABLE 110 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY TYPE, 2015
TABLE 111 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY OWNERSHIP, 2015
TOWN AND VILLAGE HOSPITALS
TABLE 112 NUMBER OF CITY AND COUNTY HOSPITALS IN CHINA BY TYPE, 2015
CHAPTER 8 CHINESE INFECTIOUS DISEASE DRUG MARKET BY GEOGRAPHY
CHINESE GEOGRAPHY
CHINESE INFECTIOUS DISEASE DRUG MARKET BY GEOGRAPHY
TABLE 113 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 34 VALUE OF THE CHINESE COMMUNICABLE INFECTIOUS DISEASE DRUG MARKET BY MAJOR REGION, 2015-2021 ($ MILLIONS)
NORTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
TABLE 114 VALUES OF THE NORTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
TABLE 115 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN NORTH CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
EAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
TABLE 116 VALUES OF THE EAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
TABLE 117 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN EAST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
SOUTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
TABLE 118 VALUES OF THE SOUTH CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
TABLE 119 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE SOUTH CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
MIDDLE CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
TABLE 120 VALUES OF THE MIDDLE CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
TABLE 121 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE MIDDLE CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
NORTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
TABLE 122 VALUES OF THE NORTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
TABLE 123 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE NORTHWEST CHINA MARKET BYPROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
SOUTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
TABLE 124 VALUES OF THE SOUTHWEST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
TABLE 125 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE SOUTHWEST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
NORTHEAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE
TABLE 126 VALUES OF THE NORTHEAST CHINA INFECTIOUS DISEASE DRUG MARKET BY PROVINCE, THROUGH 2021 ($ MILLIONS)
TABLE 127 VALUES OF INFECTIOUS DISEASE DRUGS, POPULATION AND AVERAGE CONSUMPTION IN THE NORTHEAST CHINA MARKET BY PROVINCE, 2015 ($ MILLIONS/THOUSANDS/AVERAGE)
CHINESE INFECTIOUS DRUG MARKET BY PROVINCE
TABLE 128 VALUE OF THE CHINESE INFECTIOUS DISEASE DRUG MARKET BY MAJOR PRODUCT, THROUGH 2021 ($ MILLIONS)
CHAPTER 9 INDUSTRY STRUCTURE AND MARKET STRATEGIES
FIGURE 35 DRUG SUPPLY CHAIN IN CHINA
DRUGMAKERS
FOREIGN DRUGMAKERS
Government Relationship
First- and Second-Tier Cities
Sales Channels
HOMEGROWN DRUGMAKERS
Government Relationship
Third- and Fourth-Tier Cities
Sales Channels
DRUG WHOLESALERS
DRUG RETAILERS
EXCLUSIVE DISTRIBUTORS
HOSPITALS
RETAILERS
END CONSUMERS
CHAPTER 10 COMPANY PROFILES
ANHUI BIOCHEM UNITED PHARMACEUTICAL CO. LTD.
BAYER CHINA LTD.
BEIJING TONG REN TANG
BRISTOL-MYERS SQUIBB (CHINA) INVESTMENT CO. LTD.
CHIATAI TIANQING PHARMACEUTICAL GROUP CO. LTD.
CHINA PHARMACEUTICAL UNIVERSITY PHARMACEUTICAL CO. LTD.
(CPU-PHARMA)
CHONGQING KERUI PHARMACEUTICAL CO. LTD.
CHONGQING LUMMY PHARMACEUTICAL CO. LTD.
DASHENLIN
DAWNRAYS PHARMACEUTICAL (HOLDINGS) LTD.
SUZHOU DAWNRAYS PHARMACEUTICAL CO. LTD.
EBANG PHARMACEUTICAL
FUJIAN COSUNTER PHARMACEUTICAL CO. LTD.
FUREN HUAIQINGTANG PHARMACEUTICAL CO. LTD.
GSK CHINA
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDING CO. LTD.
BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY
GUANGZHOU BAIYUNSHAN TIANXIN PHARMACEUTICAL CO. LTD.
GUANGZHOU BAIYUNSHAN GUANGHUA PHARMACEUTICAL CO. LTD.
BAIYUNSHAN CHEMICAL PHARMACEUTICAL FACTORY
GUODA DRUGSTORE
HARBIN PHARMACEUTICAL GROUP HOLDING CO. LTD.
HUNAN QIANJIN XIANGJIANG PHARMACEUTICAL INDUSTRY CO. LTD.
HUNAN XINHUI PHARMACEUTICAL CO. LTD.
JIANGSU WUZHONG PHARMACEUTICAL GROUP CORPORATION
KELUN INDUSTRY GROUP & SICHUAN KELUN PHARMACEUTICAL CO. LTD.
LUOXIN PHARMACEUTICAL
MEDFRON
MSD CHINA
NORTH CHINA PHARMACEUTICAL GROUP
PANBIOTIC
PFIZER CHINA
QILU PHARMACEUTICAL CO. LTD.
QINGFENG PHARMACEUTICAL GROUP
REYOUNG PHARMACEUTICAL CO. LTD.
ROCHE CHINA
RUNDU PHARMA
SHANDONG LUKANG PHARMACEUTICAL CO. LTD.
SHANDONG RUNZE PHARMACEUTICAL CO. LTD.
SUMITOMO PHARMACEUTICALS (SUZHOU) CO. LTD.
TUNGSHUN PHARMACEUTICAL
WATERSTONE PHARMACEUTICALS
YONGNING PHARMA
YOUCARE PHARMACEUTICAL GROUP CO. LTD.
YUNG SHIN PHARM. IND. (KUNSHAN) CO. LTD.
ZHEJIANG HISUN PHARMACEUTICAL CO. LTD.
ZHEJIANG MEDICINE CO. LTD.
ZHIJUN PHARMACEUTICAL CO. LTD.
ZHUHAI UNITED LABORATORIES CO. LTD.
CHAPTER 11 APPENDIX
GLOSSARY

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report